Aslam, M. M., Fan, K., Dang, L. T., Gorijala, P., Shi, R., Feingold, E., Xicota, L., Cohen, A. D., Handen, B. L., Christian, B. T., Head, E., Mapstone, M., Cruchaga, C., Lee, J. H., & Kamboh, M. I. (2024). Genome‐wide association of Amyloid imaging and plasma biomarkers in Adults with Down Syndrome. Alzheimer’s & Dementia, 20(S2). Portico. https://doi.org/10.1002/alz.092659

Fan, K., Aslam, M. M., Dang, L. T., Gorijala, P., Shi, R., Feingold, E., Kamboh, M. I., Lee, J. H., Xicota, L., Cohen, A. D., Handen, B. L., Christian, B. T., Head, E., Mapstone, M., & Cruchaga, C. (2024). Genome‐wide association of Tau imaging and plasma biomarkers in adults with Down Syndrome. Alzheimer’s & Dementia, 20(S2). Portico. https://doi.org/10.1002/alz.092615

Lao, P. J., Edwards, N. C., Flores‐Aguilar, L., Rizvi, B., Smith, A. C., Tudorascu, D., Rosas, H. D., Yassa, M. A., Handen, B. L., Christian, B. T., Gutierrez, J., Wilcock, D. M., Head, E., & Brickman, A. M. (2024). Longitudinal changes in neuroimaging markers of small vessel disease: Implications for clinical trials. Alzheimer’s & Dementia, 20(S9). Portico. https://doi.org/10.1002/alz.094386

Kennedy, J. T., Wisch, J. K., Gordon, B. A., Boerwinkle, A. H., Benzinger, T. L. S., Klunk, W. E., Rafii, M., O’Bryant, S. E., Price, J. C., Yassa, M. A., Sathishkumar, M., McMillan, L., Brickman, A. M., Lao, P. J., Laymon, C. M., Krinsky‐McHale, S. J., Lai, F., Rosas, H. D., … Hartley, S. L. (2024). Brain Volumetric Trajectories in Down Syndrome and Autosomal Dominant Alzheimer Disease. Alzheimer’s & Dementia, 20(S2). Portico. https://doi.org/10.1002/alz.089313

Edwards, N. C., Lao, P. J., Alshikho, M. J., Rizvi, B., Aguilar, L. F., Petersen, M., O’Bryant, S. E., Tudorascu, D., Handen, B. L., Gutierrez, J., Wilcock, D. M., Head, E., & Brickman, A. M. (2024). Independent and interactive contributions of cerebrovascular disease, neuroinflammation, and tau pathophysiology to Alzheimer’s disease‐related diagnostic conversion in adults with Down syndrome. Alzheimer’s & Dementia, 20(S2). Portico. https://doi.org/10.1002/alz.087570

Boerwinkle, A. H., Wisch, J. K., Handen, B. L., Head, E., Mapstone, M., Rafii, M. S., O’Bryant, S. E., Krinsky‐McHale, S. J., Lai, F., Rosas, H. D., Zaman, S., Lott, I. T., Tudorascu, D., Zammit, M., Brickman, A. M., Lee, J. H., & Ances, B. M. (2024). The mediating role of plasma glial fibrillary acidic protein in amyloid and tau pathology in Down’s syndrome. Alzheimer’s & Dementia. Portico. https://doi.org/10.1002/alz.14359

Wisch, J. K., Gordon, B. A., Boerwinkle, A. H., Flores, S., McKay, N. S., Henson, R. L., Thippabhotla, S., Kennedy, J. T., Butt, O. H., Chen, C. D., Handen, B. L., Christian, B. T., Head, E., Mapstone, M., Tudorascu, D., Zammit, M. D., Cohen, A., Johnson, S. C., … Fagan, A. M. (2023). Cross‐sectional comparison of the role of tau burden among Down Syndrome Alzheimer disease and autosomal‐dominant Alzheimer disease. Alzheimer’s & Dementia, 19(S14). Portico. https://doi.org/10.1002/alz.079102

Lao, P. J., Sedaghat, A., Edwards, N. C., Lippert, R. V., Rizvi, B., Smith, A. C., Tudorascu, D., Rosas, H. D., Yassa, M. A., Handen, B. L., Christian, B. T., Gutierrez, J., Wilcock, D. M., Head, E., & Brickman, A. M. (2023). Pseudo‐longitudinal trajectories of cerebrovascular disease biomarkers in adults with Down syndrome across the lifespan. Alzheimer’s & Dementia, 19(S10). Portico. https://doi.org/10.1002/alz.081900

Kennedy, J. T., Dincer, A., Thippabhotla, S., Roman, J., Wisch, J. K., Gordon, B. A., Boerwinkle, A. H., Flores, S., Chen, C. D., Benzinger, T. L. S., Klunk, W. E., Rafii, M. S., O’Bryant, S. E., Price, J. C., Yassa, M. A., Sathishkumar, M., McMillan, L., Brickman, A. M., … Lao, P. J. (2023). Changes in cortical thickness along the Alzheimer disease continuum in people with Down syndrome. Alzheimer’s & Dementia, 19(S17). Portico. https://doi.org/10.1002/alz.079932

Lao, P. J., Sedaghat, A., Edwards, N. C., Lippert, R. V., Rizvi, B., Smith, A. C., Tudorascu, D., Rosas, H. D., Yassa, M. A., Handen, B. L., Christian, B. T., Gutierrez, J., Wilcock, D. M., Head, E., & Brickman, A. M. (2023). Pseudo‐longitudinal trajectories of cerebrovascular disease biomarkers in adults with Down syndrome across the lifespan. Alzheimer’s & Dementia, 19(S13). Portico. https://doi.org/10.1002/alz.079407

Gorijala, P., Aslam, M. M., Dang, L., Fernandez, V., Sung, Y. J., Fan, K., Feingold, E., Kamboh, M. I., Lee, J. H., & Cruchaga, C. (2023). Alzheimer’s polygenic risk score is associated with Dementia and memory phenotypes in Down syndrome. Alzheimer’s & Dementia, 19(S12). Portico. https://doi.org/10.1002/alz.074937

Brickman, A. M., Lao, P. J., Edwards, N. C., Rizvi, B., Wilcock, D. M., Gutierrez, J., & Head, E. (2023). Cerebrovascular features of Alzheimer’s disease in adults with Down syndrome. Alzheimer’s & Dementia, 19(S12). Portico. https://doi.org/10.1002/alz.075678

Dang, L. T., Petersen, M., Xicota, L., O’Bryant, S. E., Krinsky‐McHale, S. J., Mapstone, M., Kamboh, M. I., Cruchaga, C., Handen, B. L., Pang, D., Silverman, W., Schupf, N., & Lee, J. H. (2023). Genome‐wide association meta‐analysis of plasma neurofilament light levels in high‐risk adults with Down Syndrome. Alzheimer’s & Dementia, 19(S14). Portico. https://doi.org/10.1002/alz.079001

Queder, N., Adams, J. N., Keator, D. B., McMillan, L., Sathishkumar, M., Taylor, L. M., Doran, E., Nguyen, D., Hom, C., Krinsky‐McHale, S. J., Price, J. C., Lai, F., Rosas, H. D., Petersen, M., O’Bryant, S. E., Brickman, A. M., Head, E., Mapstone, M., Schupf, N., … Yassa, M. A. (2023). Association Between Neuroimaging Biomarkers, Plasma NfL, and Memory Performance in Adults With Down Syndrome With and Without Dementia. Alzheimer’s & Dementia, 19(S17). Portico. https://doi.org/10.1002/alz.078029

Queder, N., Adams, J. N., Keator, D. B., McMillan, L., Sathishkumar, M., Taylor, L. M., Doran, E., Nguyen, D., Hom, C., Krinsky‐McHale, S. J., Price, J. C., Lai, F., Rosas, H. D., Petersen, M., O’Bryant, S. E., Brickman, A. M., Head, E., Mapstone, M., Schupf, N., … Yassa, M. A. (2023). Association Between Neuroimaging Biomarkers, Plasma NfL, and Memory Performance in Adults With Down Syndrome With and Without Dementia. Alzheimer’s & Dementia, 19(S10). Portico. https://doi.org/10.1002/alz.081782

Gorijala, P., Aslam, M. M., Dang, L. T., Xicota, L., Fernandez, M. V., Sung, Y. J., Fan, K., Feingold, E., Surace, E. I., Chhatwal, J. P., Hom, C. L., Hartley, S. L., Hassenstab, J., Perrin, R. J., Mapstone, M., Zaman, S. H., Ances, B. M., Kamboh, M. I., … Lee, J. H. (2023). Alzheimer’s polygenic risk scores are associated with cognitive phenotypes in Down syndrome. Alzheimer’s & Dementia, 20(2), 1038–1049. Portico. https://doi.org/10.1002/alz.13506

McLachlan, M., Price, J. C., Laymon, C. M., Garimella, A., Keator, D. B., Kreisl, W. C., Klunk, W. E., Fryer, T. D., McVea, A. K., DiFilippo, A. H., & Christian, B. T. (2022). Early striatal amyloid signal in Down Syndrome: Comparison of PiB and Florbetapir PET. Alzheimer’s & Dementia, 18(S5). Portico. https://doi.org/10.1002/alz.062459

Petersen, M., Rafii, M. S., Zhang, F., Schupf, N., Hall, J. R., & O’Bryant, S. (2021). Utility of total tau as a biomarker for Alzheimer’s disease among adults with Down syndrome. Alzheimer’s & Dementia, 17(S4). Portico. https://doi.org/10.1002/alz.052886

Dang, L. T., Krinsky‐McHale, S. J., O’Bryant, S., Pang, D., Zigman, W. B., Silverman, W., Schupf, N., & Lee, J. H. (2021). Sex differences in levels of plasma neurofilament light and total tau in adults with Down syndrome. Alzheimer’s & Dementia, 17(S5). Portico. https://doi.org/10.1002/alz.055785